GlassScriptPhysician profile
Christina Kushnir
NPI 1376741793
$502,183.54
in general payments reported to CMS, 2019-2025
39 companies · $22K in 2025
The $22K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58K · 2020: $72K · 2021: $169K · 2022: $53K · 2023: $81K · 2024: $47K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $118K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Consulting Fee: $6,890 · Travel and Lodging: $6,481 · Food and Beverage: $5,191 · Gift: $56.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $117,900.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,500.00 |
| Consulting Fee | $6,890.00 |
| Travel and Lodging | $6,481.07 |
| Food and Beverage | $5,191.04 |
| Gift | $56.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $491,324.19 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Conmed Corporation | $4,300.00 | 2023-2024 | Airseal |
| Medical Device Business Services, INC. | $3,234.14 | 2023-2024 | Echelon Flex, Ethicon, Harmonic |
| Glaxosmithkline, LLC. | $656.24 | 2019-2025 | Zejula, Jemperli |
| Astrazeneca Pharmaceuticals LP | $321.93 | 2019-2023 | Imfinzi |
| Merck Sharp & Dohme LLC | $276.69 | 2019-2023 | Keytruda, Lynparza |
| Eisai INC. | $250.13 | 2020-2023 | |
| Ethicon US, LLC | $183.76 | 2020-2024 | Harmonic, Mega Soft, Enseal |
| Abbvie INC. | $178.66 | 2019-2025 | |
| Amgen INC. | $161.50 | 2019-2020 | |
| Allergan, INC. | $153.90 | 2019 | |
| Genmab U.S., INC. | $153.16 | 2022-2023 | Tivdak |
| Hologic Sales and Service, LLC | $123.19 | 2024-2025 | Omni Hysteroscope, Fetal Fibronectin Enzyme Immunoassay, Aptima |
| Tesaro, INC. | $94.52 | 2019 | |
| Coloplast Corp | $90.44 | 2019-2022 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $82.29 | 2023-2024 | Veozah, Myrbetriq |
| Caldera Medical, INC | $56.32 | 2023 | Desara |
| Clovis Oncology, INC. | $47.43 | 2019-2020 | |
| Axonics, INC. | $43.50 | 2021-2023 | Bulkamid, Axonics |
| Myriad Genetic Laboratories, INC. | $38.61 | 2021-2022 | |
| Smith+Nephew, INC. | $36.64 | 2022 | |
| Medtronic, INC. | $34.85 | 2022-2024 | Signia |
| Tersera Therapeutics LLC | $33.59 | 2023 | Quzyttir |
| Foundation Medicine, INC. | $28.37 | 2019 | |
| Dilon Technologies, INC. | $26.69 | 2023 | Hemoblast Bellows |
| Immunogen, INC. | $25.88 | 2023 | Elahere |
| Tactile Systems Technology INC | $24.75 | 2020 | |
| Sumitomo Pharma America, INC. | $20.17 | 2023 | Gemtesa |
| Kci USA, INC. | $18.23 | 2020 | |
| Pfizer INC. | $17.89 | 2023 | |
| Minerva Surgical, INC | $17.85 | 2025 | |
| Gynesonics, INC. | $17.81 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Mylan Institutional INC. | $17.61 | 2019 | |
| Duchesnay USA Incorporated | $17.33 | 2019 | |
| Biom'Up France Sas | $16.57 | 2020 | |
| Kerecis Limited | $15.92 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Coherus Oncology, INC. | $15.53 | 2023 | |
| Boston Scientific Corporation | $15.17 | 2019 | |
| Cook Medical LLC | $12.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Kushnir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.